<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>136(2)</volume><submitter>Li Y</submitter><pubmed_abstract>Protectin DX (PDX) is a member of the superfamily of specialized proresolving mediators and exerts anti-inflammatory actions in animal models; however, its signaling mechanism remains unclear. Here, we demonstrate the analgesic actions of PDX in a mouse model of tibial fracture-induced postoperative pain (fPOP). Intravenous early- and late-phase treatment of PDX (100 ng/mouse) effectively alleviated fPOP. Compared with protectin D1 (PD1)/neuroprotectin D1, DHA, steroids, and meloxicam, PDX provided superior pain relief. While dexamethasone and meloxicam prolonged fPOP, PDX shortened the pain duration. The analgesic effects of PDX were abrogated in Gpr37-/- mice, which displayed deficits in fPOP resolution. PDX was shown to bind GPR37 and induce calcium responses in peritoneal macrophages. </pubmed_abstract><journal>The Journal of clinical investigation</journal><pagination>e190754</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12807480</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Protectin DX resolves fracture-induced postoperative pain in mice via neuronal signaling and GPR37-activated macrophage efferocytosis.</pubmed_title><pmcid>PMC12807480</pmcid><pubmed_authors>Bang S</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Ji RR</pubmed_authors><pubmed_authors>Lee M</pubmed_authors><pubmed_authors>Serhan CN</pubmed_authors><pubmed_authors>Ji J</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Chandra S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protectin DX resolves fracture-induced postoperative pain in mice via neuronal signaling and GPR37-activated macrophage efferocytosis.</name><description>Protectin DX (PDX) is a member of the superfamily of specialized proresolving mediators and exerts anti-inflammatory actions in animal models; however, its signaling mechanism remains unclear. Here, we demonstrate the analgesic actions of PDX in a mouse model of tibial fracture-induced postoperative pain (fPOP). Intravenous early- and late-phase treatment of PDX (100 ng/mouse) effectively alleviated fPOP. Compared with protectin D1 (PD1)/neuroprotectin D1, DHA, steroids, and meloxicam, PDX provided superior pain relief. While dexamethasone and meloxicam prolonged fPOP, PDX shortened the pain duration. The analgesic effects of PDX were abrogated in Gpr37-/- mice, which displayed deficits in fPOP resolution. PDX was shown to bind GPR37 and induce calcium responses in peritoneal macrophages. </description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-06T14:44:18.376Z</modification><creation>2026-06-01T03:07:01.208Z</creation></dates><accession>S-EPMC12807480</accession><cross_references><pubmed>41542772</pubmed><doi>10.1172/JCI190754</doi></cross_references></HashMap>